Viewing Study NCT06206733

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:59 AM
Ignite Modification Date: 2026-07-05 @ 5:42 AM
Study NCT ID: NCT06206733
Status: RECRUITING
Last Update Posted: 2024-03-25
First Post: 2023-12-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: ASKB589 in Combination With CAPOX and PD-1 Inhibitor in Patients With Advanced or Metastatic GC/GEJ Adenocarcinoma
Sponsor: AskGene Pharma, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastroesophageal Junction Adenocarcinoma View
None Gastric Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CLDN 18.2 View
None Gastric Adenocarcinoma View
None Gastroesophageal Junction Adenocarcinoma View
None ASKB589 View